NCT01556165View on ClinicalTrials.gov

Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2013

Conditions
Parkinson's Disease
Interventions
DRUG

rasagiline

1 mg/day, tablets, once daily, orally

DRUG

placebo

tablets, once daily, orally

Trial Locations (15)

100034

CN015, Beijing

100730

CN001, Beijing

200025

CN012, Shanghai

200040

CN007, Shanghai

200127

CN013, Shanghai

215004

CN006, Suzhou

310009

CN004, Hangzhou

430022

CN009, Wuhan

430030

CN016, Wuhan

510120

CN003, Guangzhou

510180

CN005, Guangzhou

510260

CN017, Guangzhou

610041

CN011, Chengdu

710032

CN010, Xi'an

710061

CN014, Xi'an

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT01556165 - Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China | Biotech Hunter | Biotech Hunter